Global At-Home Diagnostic Testing Market By Indications (Allergy, Anemia, Cholesterol, Drug Abuse, Colorectal Screening, Glucose, Hepatitis C, HIV, Ovulation predictor, Pregnancy, Urinary Tract Infections, Yeast infections, COVID-19, Others); By Sample Type (Urine, Blood, Saliva, Stool); By Age Group (Kids, Adults); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031

Report ID :AMI-1590 | Category : Healthcare & IT | Published Date : July, 2023 | Pages : 402 | Format :PDF

Global At-Home Diagnostic Testing Market Garnered Revenue Worth US$ 5.92 Bn in 2022, Growing at an Estimated CAGR of 5.31% from 2023- 2031.  

At-home diagnostics tests, also known as self-testing or self-diagnostic kits, are medical tests that individuals can perform on themselves in the comfort of their own homes. These tests are designed to provide users with information about their health status, detect certain conditions or diseases, or monitor specific parameters without the need for a healthcare professional or a laboratory setting. These tests usually come with clear and user-friendly instructions, including step-by-step guidance on how to collect samples and interpret the results. Some kits may also provide additional resources like instructional videos or helplines.

The global at-home diagnostic testing market has witnessed significant growth in recent years, driven by several key factors that are mentioned below:

Increasing Demand for Convenient Healthcare: At-home diagnostic tests offer convenience and accessibility, allowing individuals to perform certain tests without the need for healthcare facility visits. With busy lifestyles and the need for social distancing during the COVID-19 pandemic, at-home testing has become an attractive option for many people, leading to increased demand.

Technological Advancements: Advances in technology have played a crucial role in the growth of at-home diagnostic testing market. The development of user-friendly test kits, portable devices, and digital platforms has made it easier for individuals to perform tests and interpret results at home. Technologies such as rapid point-of-care testing, digital connectivity, and remote monitoring have improved the accuracy, efficiency, and usability of at-home diagnostic tests.

Rising Prevalence of Chronic Diseases: The global burden of chronic diseases such as diabetes, cardiovascular diseases, and respiratory conditions is increasing. At-home diagnostic tests enable individuals to monitor and manage these chronic conditions more effectively. The ability to regularly test key health parameters, such as blood glucose levels or blood pressure, empowers individuals to take proactive measures in their healthcare.

The growth of the global at-home diagnostic testing market is likely to be hampered owing to lack of professional guidance, limited test range and complexity along with accuracy and reliability concerns. For instance, at-home diagnostic tests may not provide the same level of professional guidance as tests conducted in healthcare settings. In some cases, individuals may misinterpret results or lack appropriate support for result interpretation and follow-up care.

Global At-Home Diagnostic Testing Market Revenue & Forecast, (US$ Million), 2015 – 2031 


Global At-Home Diagnostic Testing Market

Based on age group, adults dominated the at-home diagnostic testing market in 2022. At-home diagnostic tests provide opportunities for adults to engage in preventive health screening. Tests such as colon cancer screening, where individuals can collect stool samples at home, allow for early detection of potential health issues. Similarly, tests for STIs, such as HIV or chlamydia, enable adults to engage in regular screening for sexually transmitted infections.  With the global population aging, at-home diagnostic tests cater to the needs of older adults who may face challenges in accessing healthcare services. These tests allow them to monitor chronic conditions, such as diabetes or cardiovascular diseases, conveniently from home, empowering them to take an active role in managing their health. Furthermore, at-home diagnostic tests also cater to adults interested in monitoring their general health and wellness. For example, wearable devices or home-based tests that track parameters like sleep quality, activity levels, or stress markers provide insights into overall health and well-being. These tests allow adults to take a proactive approach to their health and make informed lifestyle choices.

North America has a well-developed market for at-home diagnostic testing market and was a significant revenue generator in 2022. A wide range of at-home test kits and devices are available for various health conditions and wellness monitoring. These tests can be purchased over-the-counter at pharmacies, online platforms, or directly from manufacturers. The COVID-19 pandemic has further accelerated the demand for at-home diagnostic testing market in North America. At-home COVID-19 test kits, including rapid antigen tests and PCR tests, have become widely available to facilitate widespread testing, monitoring, and surveillance. Regulatory agencies have provided Emergency Use Authorizations (EUAs) for certain at-home COVID-19 testing options to expedite their availability. Furthermore, the integration of at-home diagnostic testing with telemedicine platforms and remote healthcare services has gained traction in North America. Telehealth consultations, where healthcare providers guide patients through at-home tests and interpret the results remotely, have enhanced accessibility to healthcare and further facilitated the adoption of at-home diagnostic testing market.

Competitive Landscape

The report provides both, qualitative and quantitative research of global at-home diagnostic testing market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.

Some of the players operating in the global at-home diagnostic testing market are:

  • 23andMe
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY Inc.
  • B. Braun Medical Ltd
  • BD (Becton, Dickinson and Company)
  • Bionime Corporation
  • Everlywell
  • F. Hoffmann-La Roche Ltd
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Other Market Participants

Global At-Home Diagnostic Testing Market

By Indications 

  • Allergy
  • Anemia
  • Cholesterol
  • Drug abuse
  • Colorectal Screening
  • Glucose
  • Hepatitis C
  • HIV
  • Ovulation predictor
  • Pregnancy
  • Urinary tract infections
  • Yeast infections
  • COVID-19
  • Others

By Sample Type 

  • Urine
  • Blood
  • Saliva
  • Stool

By Age Group 

  • Kids
  • Adults

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)   


Table of Contents

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2021

1.2.2. Base Year: 2022

1.2.3. Forecast Years: 2023 - 2031

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of At-Home Diagnostic Testing Market

6.    Market Synopsis:  At-Home Diagnostic Testing Market

7.    At-Home Diagnostic Testing Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in At-Home Diagnostic Testing Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: At-Home Diagnostic Testing Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on At-Home Diagnostic Testing Market

8.    Global At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

8.1. Overview

8.1.1. Global At-Home Diagnostic Testing Market Revenue (US$ Mn)

8.2. Global At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

8.2.1. Allergy

8.2.1.1.    Definition

8.2.1.2.    Market Estimation and Penetration, 2015 - 2022

8.2.1.3.    Market Forecast, 2023 - 2031

8.2.1.4.    Compound Annual Growth Rate (CAGR)

8.2.1.5.    Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 - 2022

8.2.1.5.1.2. Market Forecast, 2023 - 2031

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 - 2022

8.2.1.5.2.2. Market Forecast, 2023 - 2031

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 - 2022

8.2.1.5.3.2. Market Forecast, 2023 - 2031

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 - 2022

8.2.1.5.4.2. Market Forecast, 2023 - 2031

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 - 2022

8.2.1.5.5.2. Market Forecast, 2023 - 2031

8.2.2. Anemia

8.2.2.1.    Definition

8.2.2.2.    Market Estimation and Penetration, 2015 - 2022

8.2.2.3.    Market Forecast, 2023 - 2031

8.2.2.4.    Compound Annual Growth Rate (CAGR)

8.2.2.5.    Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 - 2022

8.2.2.5.1.2. Market Forecast, 2023 - 2031

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2022

8.2.2.5.2.2. Market Forecast, 2023 - 2031

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2022

8.2.2.5.3.2. Market Forecast, 2023 - 2031

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2022

8.2.2.5.4.2. Market Forecast, 2023 - 2031

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2022

8.2.2.5.5.2. Market Forecast, 2023 - 2031

8.2.3. Cholesterol

8.2.3.1.    Definition

8.2.3.2.    Market Estimation and Penetration, 2015 - 2022

8.2.3.3.    Market Forecast, 2023 - 2031

8.2.3.4.    Compound Annual Growth Rate (CAGR)

8.2.3.5.    Regional Bifurcation

8.2.3.5.1. North America

8.2.3.5.1.1. Market Estimation, 2015 - 2022

8.2.3.5.1.2. Market Forecast, 2023 - 2031

8.2.3.5.2. Europe

8.2.3.5.2.1. Market Estimation, 2015 - 2022

8.2.3.5.2.2. Market Forecast, 2023 - 2031

8.2.3.5.3. Asia Pacific

8.2.3.5.3.1. Market Estimation, 2015 - 2022

8.2.3.5.3.2. Market Forecast, 2023 - 2031

8.2.3.5.4. Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2015 - 2022

8.2.3.5.4.2. Market Forecast, 2023 - 2031

8.2.3.5.5. Latin America

8.2.3.5.5.1. Market Estimation, 2015 - 2022

8.2.3.5.5.2. Market Forecast, 2023 - 2031

8.2.4. Drug abuse

8.2.4.1.    Definition

8.2.4.2.    Market Estimation and Penetration, 2015 - 2022

8.2.4.3.    Market Forecast, 2023 - 2031

8.2.4.4.    Compound Annual Growth Rate (CAGR)

8.2.4.5.    Regional Bifurcation

8.2.4.5.1. North America

8.2.4.5.1.1. Market Estimation, 2015 - 2022

8.2.4.5.1.2. Market Forecast, 2023 - 2031

8.2.4.5.2. Europe

8.2.4.5.2.1. Market Estimation, 2015 - 2022

8.2.4.5.2.2. Market Forecast, 2023 - 2031

8.2.4.5.3. Asia Pacific

8.2.4.5.3.1. Market Estimation, 2015 - 2022

8.2.4.5.3.2. Market Forecast, 2023 - 2031

8.2.4.5.4. Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2015 - 2022

8.2.4.5.4.2. Market Forecast, 2023 - 2031

8.2.4.5.5. Latin America

8.2.4.5.5.1. Market Estimation, 2015 - 2022

8.2.4.5.5.2. Market Forecast, 2023 - 2031

8.2.5. Colorectal Screening

8.2.5.1.    Definition

8.2.5.2.    Market Estimation and Penetration, 2015 - 2022

8.2.5.3.    Market Forecast, 2023 - 2031

8.2.5.4.    Compound Annual Growth Rate (CAGR)

8.2.5.5.    Regional Bifurcation

8.2.5.5.1. North America

8.2.5.5.1.1. Market Estimation, 2015 - 2022

8.2.5.5.1.2. Market Forecast, 2023 - 2031

8.2.5.5.2. Europe

8.2.5.5.2.1. Market Estimation, 2015 - 2022

8.2.5.5.2.2. Market Forecast, 2023 - 2031

8.2.5.5.3. Asia Pacific

8.2.5.5.3.1. Market Estimation, 2015 - 2022

8.2.5.5.3.2. Market Forecast, 2023 - 2031

8.2.5.5.4. Middle East and Africa

8.2.5.5.4.1. Market Estimation, 2015 - 2022

8.2.5.5.4.2. Market Forecast, 2023 - 2031

8.2.5.5.5. Latin America

8.2.5.5.5.1. Market Estimation, 2015 - 2022

8.2.5.5.5.2. Market Forecast, 2023 - 2031

8.2.6. Glucose

8.2.6.1.    Definition

8.2.6.2.    Market Estimation and Penetration, 2015 - 2022

8.2.6.3.    Market Forecast, 2023 - 2031

8.2.6.4.    Compound Annual Growth Rate (CAGR)

8.2.6.5.    Regional Bifurcation

8.2.6.5.1. North America

8.2.6.5.1.1. Market Estimation, 2015 - 2022

8.2.6.5.1.2. Market Forecast, 2023 - 2031

8.2.6.5.2. Europe

8.2.6.5.2.1. Market Estimation, 2015 - 2022

8.2.6.5.2.2. Market Forecast, 2023 - 2031

8.2.6.5.3. Asia Pacific

8.2.6.5.3.1. Market Estimation, 2015 - 2022

8.2.6.5.3.2. Market Forecast, 2023 - 2031

8.2.6.5.4. Middle East and Africa

8.2.6.5.4.1. Market Estimation, 2015 - 2022

8.2.6.5.4.2. Market Forecast, 2023 - 2031

8.2.6.5.5. Latin America

8.2.6.5.5.1. Market Estimation, 2015 - 2022

8.2.6.5.5.2. Market Forecast, 2023 - 2031

8.2.7. Hepatitis C

8.2.7.1.    Definition

8.2.7.2.    Market Estimation and Penetration, 2015 - 2022

8.2.7.3.    Market Forecast, 2023 - 2031

8.2.7.4.    Compound Annual Growth Rate (CAGR)

8.2.7.5.    Regional Bifurcation

8.2.7.5.1. North America

8.2.7.5.1.1. Market Estimation, 2015 - 2022

8.2.7.5.1.2. Market Forecast, 2023 - 2031

8.2.7.5.2. Europe

8.2.7.5.2.1. Market Estimation, 2015 - 2022

8.2.7.5.2.2. Market Forecast, 2023 - 2031

8.2.7.5.3. Asia Pacific

8.2.7.5.3.1. Market Estimation, 2015 - 2022

8.2.7.5.3.2. Market Forecast, 2023 - 2031

8.2.7.5.4. Middle East and Africa

8.2.7.5.4.1. Market Estimation, 2015 - 2022

8.2.7.5.4.2. Market Forecast, 2023 - 2031

8.2.7.5.5. Latin America

8.2.7.5.5.1. Market Estimation, 2015 - 2022

8.2.7.5.5.2. Market Forecast, 2023 - 2031

8.2.8. HIV

8.2.8.1.    Definition

8.2.8.2.    Market Estimation and Penetration, 2015 - 2022

8.2.8.3.    Market Forecast, 2023 - 2031

8.2.8.4.    Compound Annual Growth Rate (CAGR)

8.2.8.5.    Regional Bifurcation

8.2.8.5.1. North America

8.2.8.5.1.1. Market Estimation, 2015 - 2022

8.2.8.5.1.2. Market Forecast, 2023 - 2031

8.2.8.5.2. Europe

8.2.8.5.2.1. Market Estimation, 2015 - 2022

8.2.8.5.2.2. Market Forecast, 2023 - 2031

8.2.8.5.3. Asia Pacific

8.2.8.5.3.1. Market Estimation, 2015 - 2022

8.2.8.5.3.2. Market Forecast, 2023 - 2031

8.2.8.5.4. Middle East and Africa

8.2.8.5.4.1. Market Estimation, 2015 - 2022

8.2.8.5.4.2. Market Forecast, 2023 - 2031

8.2.8.5.5. Latin America

8.2.8.5.5.1. Market Estimation, 2015 - 2022

8.2.8.5.5.2. Market Forecast, 2023 - 2031

8.2.9. Ovulation predictor

8.2.9.1.    Definition

8.2.9.2.    Market Estimation and Penetration, 2015 - 2022

8.2.9.3.    Market Forecast, 2023 - 2031

8.2.9.4.    Compound Annual Growth Rate (CAGR)

8.2.9.5.    Regional Bifurcation

8.2.9.5.1. North America

8.2.9.5.1.1. Market Estimation, 2015 - 2022

8.2.9.5.1.2. Market Forecast, 2023 - 2031

8.2.9.5.2. Europe

8.2.9.5.2.1. Market Estimation, 2015 - 2022

8.2.9.5.2.2. Market Forecast, 2023 - 2031

8.2.9.5.3. Asia Pacific

8.2.9.5.3.1. Market Estimation, 2015 - 2022

8.2.9.5.3.2. Market Forecast, 2023 - 2031

8.2.9.5.4. Middle East and Africa

8.2.9.5.4.1. Market Estimation, 2015 - 2022

8.2.9.5.4.2. Market Forecast, 2023 - 2031

8.2.9.5.5. Latin America

8.2.9.5.5.1. Market Estimation, 2015 - 2022

8.2.9.5.5.2. Market Forecast, 2023 - 2031

8.2.10. Pregnancy

8.2.10.1.  Definition

8.2.10.2.  Market Estimation and Penetration, 2015 - 2022

8.2.10.3.  Market Forecast, 2023 - 2031

8.2.10.4.  Compound Annual Growth Rate (CAGR)

8.2.10.5.  Regional Bifurcation

8.2.10.5.1. North America

8.2.10.5.1.1. Market Estimation, 2015 - 2022

8.2.10.5.1.2. Market Forecast, 2023 - 2031

8.2.10.5.2. Europe

8.2.10.5.2.1. Market Estimation, 2015 - 2022

8.2.10.5.2.2. Market Forecast, 2023 - 2031

8.2.10.5.3. Asia Pacific

8.2.10.5.3.1. Market Estimation, 2015 - 2022

8.2.10.5.3.2. Market Forecast, 2023 - 2031

8.2.10.5.4. Middle East and Africa

8.2.10.5.4.1. Market Estimation, 2015 - 2022

8.2.10.5.4.2. Market Forecast, 2023 - 2031

8.2.10.5.5. Latin America

8.2.10.5.5.1. Market Estimation, 2015 - 2022

8.2.10.5.5.2. Market Forecast, 2023 - 2031

8.2.11. Urinary tract infections

8.2.11.1.  Definition

8.2.11.2.  Market Estimation and Penetration, 2015 - 2022

8.2.11.3.  Market Forecast, 2023 - 2031

8.2.11.4.  Compound Annual Growth Rate (CAGR)

8.2.11.5.  Regional Bifurcation

8.2.11.5.1. North America

8.2.11.5.1.1. Market Estimation, 2015 - 2022

8.2.11.5.1.2. Market Forecast, 2023 - 2031

8.2.11.5.2. Europe

8.2.11.5.2.1. Market Estimation, 2015 - 2022

8.2.11.5.2.2. Market Forecast, 2023 - 2031

8.2.11.5.3. Asia Pacific

8.2.11.5.3.1. Market Estimation, 2015 - 2022

8.2.11.5.3.2. Market Forecast, 2023 - 2031

8.2.11.5.4. Middle East and Africa

8.2.11.5.4.1. Market Estimation, 2015 - 2022

8.2.11.5.4.2. Market Forecast, 2023 - 2031

8.2.11.5.5. Latin America

8.2.11.5.5.1. Market Estimation, 2015 - 2022

8.2.11.5.5.2. Market Forecast, 2023 - 2031

8.2.12. Yeast infections

8.2.12.1.  Definition

8.2.12.2.  Market Estimation and Penetration, 2015 - 2022

8.2.12.3.  Market Forecast, 2023 - 2031

8.2.12.4.  Compound Annual Growth Rate (CAGR)

8.2.12.5.  Regional Bifurcation

8.2.12.5.1. North America

8.2.12.5.1.1. Market Estimation, 2015 - 2022

8.2.12.5.1.2. Market Forecast, 2023 - 2031

8.2.12.5.2. Europe

8.2.12.5.2.1. Market Estimation, 2015 - 2022

8.2.12.5.2.2. Market Forecast, 2023 - 2031

8.2.12.5.3. Asia Pacific

8.2.12.5.3.1. Market Estimation, 2015 - 2022

8.2.12.5.3.2. Market Forecast, 2023 - 2031

8.2.12.5.4. Middle East and Africa

8.2.12.5.4.1. Market Estimation, 2015 - 2022

8.2.12.5.4.2. Market Forecast, 2023 - 2031

8.2.12.5.5. Latin America

8.2.12.5.5.1. Market Estimation, 2015 - 2022

8.2.12.5.5.2. Market Forecast, 2023 - 2031

8.2.13. COVID-19

8.2.13.1.  Definition

8.2.13.2.  Market Estimation and Penetration, 2015 - 2022

8.2.13.3.  Market Forecast, 2023 - 2031

8.2.13.4.  Compound Annual Growth Rate (CAGR)

8.2.13.5.  Regional Bifurcation

8.2.13.5.1. North America

8.2.13.5.1.1. Market Estimation, 2015 - 2022

8.2.13.5.1.2. Market Forecast, 2023 - 2031

8.2.13.5.2. Europe

8.2.13.5.2.1. Market Estimation, 2015 - 2022

8.2.13.5.2.2. Market Forecast, 2023 - 2031

8.2.13.5.3. Asia Pacific

8.2.13.5.3.1. Market Estimation, 2015 - 2022

8.2.13.5.3.2. Market Forecast, 2023 - 2031

8.2.13.5.4. Middle East and Africa

8.2.13.5.4.1. Market Estimation, 2015 - 2022

8.2.13.5.4.2. Market Forecast, 2023 - 2031

8.2.13.5.5. Latin America

8.2.13.5.5.1. Market Estimation, 2015 - 2022

8.2.13.5.5.2. Market Forecast, 2023 - 2031

8.2.14. Others

8.2.14.1.  Definition

8.2.14.2.  Market Estimation and Penetration, 2015 - 2022

8.2.14.3.  Market Forecast, 2023 - 2031

8.2.14.4.  Compound Annual Growth Rate (CAGR)

8.2.14.5.  Regional Bifurcation

8.2.14.5.1. North America

8.2.14.5.1.1. Market Estimation, 2015 - 2022

8.2.14.5.1.2. Market Forecast, 2023 - 2031

8.2.14.5.2. Europe

8.2.14.5.2.1. Market Estimation, 2015 - 2022

8.2.14.5.2.2. Market Forecast, 2023 - 2031

8.2.14.5.3. Asia Pacific

8.2.14.5.3.1. Market Estimation, 2015 - 2022

8.2.14.5.3.2. Market Forecast, 2023 - 2031

8.2.14.5.4. Middle East and Africa

8.2.14.5.4.1. Market Estimation, 2015 - 2022

8.2.14.5.4.2. Market Forecast, 2023 - 2031

8.2.14.5.5. Latin America

8.2.14.5.5.1. Market Estimation, 2015 - 2022

8.2.14.5.5.2. Market Forecast, 2023 - 2031

8.3. Key Segment for Channeling Investments

8.3.1. By Indications

9.    Global At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

9.1. Overview

9.2. Global At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

9.2.1. Urine

9.2.1.1.    Definition

9.2.1.2.    Market Estimation and Penetration, 2015 - 2022

9.2.1.3.    Market Forecast, 2023 - 2031

9.2.1.4.    Compound Annual Growth Rate (CAGR)

9.2.1.5.    Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 - 2022

9.2.1.5.1.2. Market Forecast, 2023 - 2031

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2022

9.2.1.5.2.2. Market Forecast, 2023 - 2031

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2022

9.2.1.5.3.2. Market Forecast, 2023 - 2031

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2022

9.2.1.5.4.2. Market Forecast, 2023 - 2031

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2022

9.2.1.5.5.2. Market Forecast, 2023 - 2031

9.2.2. Blood

9.2.2.1.    Definition

9.2.2.2.    Market Estimation and Penetration, 2015 - 2022

9.2.2.3.    Market Forecast, 2023 - 2031

9.2.2.4.    Compound Annual Growth Rate (CAGR)

9.2.2.5.    Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 - 2022

9.2.2.5.1.2. Market Forecast, 2023 - 2031

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2022

9.2.2.5.2.2. Market Forecast, 2023 - 2031

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2022

9.2.2.5.3.2. Market Forecast, 2023 - 2031

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2022

9.2.2.5.4.2. Market Forecast, 2023 - 2031

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2022

9.2.2.5.5.2. Market Forecast, 2023 - 2031

9.2.3. Saliva

9.2.3.1.    Definition

9.2.3.2.    Market Estimation and Penetration, 2015 - 2022

9.2.3.3.    Market Forecast, 2023 - 2031

9.2.3.4.    Compound Annual Growth Rate (CAGR)

9.2.3.5.    Regional Bifurcation

9.2.3.5.1. North America

9.2.3.5.1.1. Market Estimation, 2015 - 2022

9.2.3.5.1.2. Market Forecast, 2023 - 2031

9.2.3.5.2. Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2022

9.2.3.5.2.2. Market Forecast, 2023 - 2031

9.2.3.5.3. Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2022

9.2.3.5.3.2. Market Forecast, 2023 - 2031

9.2.3.5.4. Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2022

9.2.3.5.4.2. Market Forecast, 2023 - 2031

9.2.3.5.5. Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2022

9.2.3.5.5.2. Market Forecast, 2023 - 2031

9.2.4. Stool

9.2.4.1.    Definition

9.2.4.2.    Market Estimation and Penetration, 2015 - 2022

9.2.4.3.    Market Forecast, 2023 - 2031

9.2.4.4.    Compound Annual Growth Rate (CAGR)

9.2.4.5.    Regional Bifurcation

9.2.4.5.1. North America

9.2.4.5.1.1. Market Estimation, 2015 - 2022

9.2.4.5.1.2. Market Forecast, 2023 - 2031

9.2.4.5.2. Europe

9.2.4.5.2.1. Market Estimation, 2015 - 2022

9.2.4.5.2.2. Market Forecast, 2023 - 2031

9.2.4.5.3. Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 - 2022

9.2.4.5.3.2. Market Forecast, 2023 - 2031

9.2.4.5.4. Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 - 2022

9.2.4.5.4.2. Market Forecast, 2023 - 2031

9.2.4.5.5. Latin America

9.2.4.5.5.1. Market Estimation, 2015 - 2022

9.2.4.5.5.2. Market Forecast, 2023 - 2031

9.3. Key Segment for Channeling Investments

9.3.1. By Sample Type

10. Global At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

10.1. Overview

10.2. Global At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

10.2.1. Kids

10.2.1.1.  Definition

10.2.1.2.  Market Estimation and Penetration, 2015 - 2022

10.2.1.3.  Market Forecast, 2023 - 2031

10.2.1.4.  Compound Annual Growth Rate (CAGR)

10.2.1.5.  Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 - 2022

10.2.1.5.1.2. Market Forecast, 2023 - 2031

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 - 2022

10.2.1.5.2.2. Market Forecast, 2023 - 2031

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 - 2022

10.2.1.5.3.2. Market Forecast, 2023 - 2031

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 - 2022

10.2.1.5.4.2. Market Forecast, 2023 - 2031

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 - 2022

10.2.1.5.5.2. Market Forecast, 2023 - 2031

10.2.2. Adults

10.2.2.1.  Definition

10.2.2.2.  Market Estimation and Penetration, 2015 - 2022

10.2.2.3.  Market Forecast, 2023 - 2031

10.2.2.4.  Compound Annual Growth Rate (CAGR)

10.2.2.5.  Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 - 2022

10.2.2.5.1.2. Market Forecast, 2023 - 2031

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 - 2022

10.2.2.5.2.2. Market Forecast, 2023 - 2031

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 - 2022

10.2.2.5.3.2. Market Forecast, 2023 - 2031

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 - 2022

10.2.2.5.4.2. Market Forecast, 2023 - 2031

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 - 2022

10.2.2.5.5.2. Market Forecast, 2023 - 2031

10.3. Key Segment for Channeling Investments

10.3.1. By Age Group

11. Global At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

11.1. Overview

11.2. Global At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

11.2.1. Retail Pharmacies

11.2.1.1.  Definition

11.2.1.2.  Market Estimation and Penetration, 2015 - 2022

11.2.1.3.  Market Forecast, 2023 - 2031

11.2.1.4.  Compound Annual Growth Rate (CAGR)

11.2.1.5.  Regional Bifurcation

11.2.1.5.1. North America

11.2.1.5.1.1. Market Estimation, 2015 - 2022

11.2.1.5.1.2. Market Forecast, 2023 - 2031

11.2.1.5.2. Europe

11.2.1.5.2.1. Market Estimation, 2015 - 2022

11.2.1.5.2.2. Market Forecast, 2023 - 2031

11.2.1.5.3. Asia Pacific

11.2.1.5.3.1. Market Estimation, 2015 - 2022

11.2.1.5.3.2. Market Forecast, 2023 - 2031

11.2.1.5.4. Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2015 - 2022

11.2.1.5.4.2. Market Forecast, 2023 - 2031

11.2.1.5.5. Latin America

11.2.1.5.5.1. Market Estimation, 2015 - 2022

11.2.1.5.5.2. Market Forecast, 2023 - 2031

11.2.2. Hospital Pharmacies

11.2.2.1.  Definition

11.2.2.2.  Market Estimation and Penetration, 2015 - 2022

11.2.2.3.  Market Forecast, 2023 - 2031

11.2.2.4.  Compound Annual Growth Rate (CAGR)

11.2.2.5.  Regional Bifurcation

11.2.2.5.1. North America

11.2.2.5.1.1. Market Estimation, 2015 - 2022

11.2.2.5.1.2. Market Forecast, 2023 - 2031

11.2.2.5.2. Europe

11.2.2.5.2.1. Market Estimation, 2015 - 2022

11.2.2.5.2.2. Market Forecast, 2023 - 2031

11.2.2.5.3. Asia Pacific

11.2.2.5.3.1. Market Estimation, 2015 - 2022

11.2.2.5.3.2. Market Forecast, 2023 - 2031

11.2.2.5.4. Middle East and Africa

11.2.2.5.4.1. Market Estimation, 2015 - 2022

11.2.2.5.4.2. Market Forecast, 2023 - 2031

11.2.2.5.5. Latin America

11.2.2.5.5.1. Market Estimation, 2015 - 2022

11.2.2.5.5.2. Market Forecast, 2023 - 2031

11.2.3. Online Pharmacies

11.2.3.1.  Definition

11.2.3.2.  Market Estimation and Penetration, 2015 - 2022

11.2.3.3.  Market Forecast, 2023 - 2031

11.2.3.4.  Compound Annual Growth Rate (CAGR)

11.2.3.5.  Regional Bifurcation

11.2.3.5.1. North America

11.2.3.5.1.1. Market Estimation, 2015 - 2022

11.2.3.5.1.2. Market Forecast, 2023 - 2031

11.2.3.5.2. Europe

11.2.3.5.2.1. Market Estimation, 2015 - 2022

11.2.3.5.2.2. Market Forecast, 2023 - 2031

11.2.3.5.3. Asia Pacific

11.2.3.5.3.1. Market Estimation, 2015 - 2022

11.2.3.5.3.2. Market Forecast, 2023 - 2031

11.2.3.5.4. Middle East and Africa

11.2.3.5.4.1. Market Estimation, 2015 - 2022

11.2.3.5.4.2. Market Forecast, 2023 - 2031

11.2.3.5.5. Latin America

11.2.3.5.5.1. Market Estimation, 2015 - 2022

11.2.3.5.5.2. Market Forecast, 2023 - 2031

11.3. Key Segment for Channeling Investments

11.3.1. By Distribution Channel

12. North America At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

12.1. Overview

12.1.1. North America At-Home Diagnostic Testing Market Revenue (US$ Mn)

12.2. North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

12.2.1. Allergy

12.2.2. Anemia

12.2.3. Cholesterol

12.2.4. Drug abuse

12.2.5. Colorectal Screening

12.2.6. Glucose

12.2.7. Hepatitis C

12.2.8. HIV

12.2.9. Ovulation predictor

12.2.10. Pregnancy

12.2.11. Urinary tract infections

12.2.12. Yeast infections

12.2.13. COVID-19

12.2.14. Others

12.3. North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

12.3.1. Urine

12.3.2. Blood

12.3.3. Saliva

12.3.4. Stool

12.4. North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

12.4.1. Kids

12.4.2. Adults

12.5. North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.5.1. Retail Pharmacies

12.5.2. Hospital Pharmacies

12.5.3. Online Pharmacies

12.6. North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Country

12.6.1. U.S

12.6.1.1.  U.S At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

12.6.1.1.1. Allergy

12.6.1.1.2. Anemia

12.6.1.1.3. Cholesterol

12.6.1.1.4. Drug abuse

12.6.1.1.5. Colorectal Screening

12.6.1.1.6. Glucose

12.6.1.1.7. Hepatitis C

12.6.1.1.8. HIV

12.6.1.1.9. Ovulation predictor

12.6.1.1.10. Pregnancy

12.6.1.1.11. Urinary tract infections

12.6.1.1.12. Yeast infections

12.6.1.1.13. COVID-19

12.6.1.1.14. Others

12.6.1.2.  U.S At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

12.6.1.2.1. Urine

12.6.1.2.2. Blood

12.6.1.2.3. Saliva

12.6.1.2.4. Stool

12.6.1.3.  U.S At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

12.6.1.3.1. Kids

12.6.1.3.2. Adults

12.6.1.4.  U.S At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.6.1.4.1. Retail Pharmacies

12.6.1.4.2. Hospital Pharmacies

12.6.1.4.3. Online Pharmacies

12.6.2. Canada

12.6.2.1.  Canada At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

12.6.2.1.1. Allergy

12.6.2.1.2. Anemia

12.6.2.1.3. Cholesterol

12.6.2.1.4. Drug abuse

12.6.2.1.5. Colorectal Screening

12.6.2.1.6. Glucose

12.6.2.1.7. Hepatitis C

12.6.2.1.8. HIV

12.6.2.1.9. Ovulation predictor

12.6.2.1.10. Pregnancy

12.6.2.1.11. Urinary tract infections

12.6.2.1.12. Yeast infections

12.6.2.1.13. COVID-19

12.6.2.1.14. Others

12.6.2.2.  Canada At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

12.6.2.2.1. Urine

12.6.2.2.2. Blood

12.6.2.2.3. Saliva

12.6.2.2.4. Stool

12.6.2.3.  Canada At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

12.6.2.3.1. Kids

12.6.2.3.2. Adults

12.6.2.4.  Canada At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.6.2.4.1. Retail Pharmacies

12.6.2.4.2. Hospital Pharmacies

12.6.2.4.3. Online Pharmacies

12.6.3. Mexico

12.6.3.1.  Mexico At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

12.6.3.1.1. Allergy

12.6.3.1.2. Anemia

12.6.3.1.3. Cholesterol

12.6.3.1.4. Drug abuse

12.6.3.1.5. Colorectal Screening

12.6.3.1.6. Glucose

12.6.3.1.7. Hepatitis C

12.6.3.1.8. HIV

12.6.3.1.9. Ovulation predictor

12.6.3.1.10. Pregnancy

12.6.3.1.11. Urinary tract infections

12.6.3.1.12. Yeast infections

12.6.3.1.13. COVID-19

12.6.3.1.14. Others

12.6.3.2.  Mexico At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

12.6.3.2.1. Urine

12.6.3.2.2. Blood

12.6.3.2.3. Saliva

12.6.3.2.4. Stool

12.6.3.3.  Mexico At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

12.6.3.3.1. Kids

12.6.3.3.2. Adults

12.6.3.4.  Mexico At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.6.3.4.1. Retail Pharmacies

12.6.3.4.2. Hospital Pharmacies

12.6.3.4.3. Online Pharmacies

12.6.4. Rest of North America

12.6.4.1.  Rest of North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

12.6.4.1.1. Allergy

12.6.4.1.2. Anemia

12.6.4.1.3. Cholesterol

12.6.4.1.4. Drug abuse

12.6.4.1.5. Colorectal Screening

12.6.4.1.6. Glucose

12.6.4.1.7. Hepatitis C

12.6.4.1.8. HIV

12.6.4.1.9. Ovulation predictor

12.6.4.1.10. Pregnancy

12.6.4.1.11. Urinary tract infections

12.6.4.1.12. Yeast infections

12.6.4.1.13. COVID-19

12.6.4.1.14. Others

12.6.4.2.  Rest of North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

12.6.4.2.1. Urine

12.6.4.2.2. Blood

12.6.4.2.3. Saliva

12.6.4.2.4. Stool

12.6.4.3.  Rest of North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

12.6.4.3.1. Kids

12.6.4.3.2. Adults

12.6.4.4.  Rest of North America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

12.6.4.4.1. Retail Pharmacies

12.6.4.4.2. Hospital Pharmacies

12.6.4.4.3. Online Pharmacies

12.7. Key Segment for Channeling Investments

12.7.1. By Country

12.7.2. By Indications

12.7.3. By Sample Type

12.7.4. By Age Group

12.7.5. By Distribution Channel

13. Europe At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

13.1. Overview

13.1.1. Europe At-Home Diagnostic Testing Market Revenue (US$ Mn)

13.2. Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.2.1. Allergy

13.2.2. Anemia

13.2.3. Cholesterol

13.2.4. Drug abuse

13.2.5. Colorectal Screening

13.2.6. Glucose

13.2.7. Hepatitis C

13.2.8. HIV

13.2.9. Ovulation predictor

13.2.10. Pregnancy

13.2.11. Urinary tract infections

13.2.12. Yeast infections

13.2.13. COVID-19

13.2.14. Others

13.3. Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.3.1. Urine

13.3.2. Blood

13.3.3. Saliva

13.3.4. Stool

13.4. Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.4.1. Kids

13.4.2. Adults

13.5. Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.5.1. Retail Pharmacies

13.5.2. Hospital Pharmacies

13.5.3. Online Pharmacies

13.6. Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Country

13.6.1. France

13.6.1.1.  France At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.6.1.1.1. Allergy

13.6.1.1.2. Anemia

13.6.1.1.3. Cholesterol

13.6.1.1.4. Drug abuse

13.6.1.1.5. Colorectal Screening

13.6.1.1.6. Glucose

13.6.1.1.7. Hepatitis C

13.6.1.1.8. HIV

13.6.1.1.9. Ovulation predictor

13.6.1.1.10. Pregnancy

13.6.1.1.11. Urinary tract infections

13.6.1.1.12. Yeast infections

13.6.1.1.13. COVID-19

13.6.1.1.14. Others

13.6.1.2.  France At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.6.1.2.1. Urine

13.6.1.2.2. Blood

13.6.1.2.3. Saliva

13.6.1.2.4. Stool

13.6.1.3.  France At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.1.3.1. Kids

13.6.1.3.2. Adults

13.6.1.4.  France At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.1.4.1. Retail Pharmacies

13.6.1.4.2. Hospital Pharmacies

13.6.1.4.3. Online Pharmacies

13.6.2. The UK

13.6.2.1.  The UK At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.6.2.1.1. Allergy

13.6.2.1.2. Anemia

13.6.2.1.3. Cholesterol

13.6.2.1.4. Drug abuse

13.6.2.1.5. Colorectal Screening

13.6.2.1.6. Glucose

13.6.2.1.7. Hepatitis C

13.6.2.1.8. HIV

13.6.2.1.9. Ovulation predictor

13.6.2.1.10. Pregnancy

13.6.2.1.11. Urinary tract infections

13.6.2.1.12. Yeast infections

13.6.2.1.13. COVID-19

13.6.2.1.14. Others

13.6.2.2.  The UK At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.6.2.2.1. Urine

13.6.2.2.2. Blood

13.6.2.2.3. Saliva

13.6.2.2.4. Stool

13.6.2.3.  The UK At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.2.3.1. Kids

13.6.2.3.2. Adults

13.6.2.4.  The UK At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.2.4.1. Retail Pharmacies

13.6.2.4.2. Hospital Pharmacies

13.6.2.4.3. Online Pharmacies

13.6.3. Spain

13.6.3.1.  Spain At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.6.3.1.1. Allergy

13.6.3.1.2. Anemia

13.6.3.1.3. Cholesterol

13.6.3.1.4. Drug abuse

13.6.3.1.5. Colorectal Screening

13.6.3.1.6. Glucose

13.6.3.1.7. Hepatitis C

13.6.3.1.8. HIV

13.6.3.1.9. Ovulation predictor

13.6.3.1.10. Pregnancy

13.6.3.1.11. Urinary tract infections

13.6.3.1.12. Yeast infections

13.6.3.1.13. COVID-19

13.6.3.1.14. Others

13.6.3.2.  Spain At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.6.3.2.1. Urine

13.6.3.2.2. Blood

13.6.3.2.3. Saliva

13.6.3.2.4. Stool

13.6.3.3.  Spain At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.3.3.1. Kids

13.6.3.3.2. Adults

13.6.3.4.  Spain At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.3.4.1. Retail Pharmacies

13.6.3.4.2. Hospital Pharmacies

13.6.3.4.3. Online Pharmacies

13.6.4. Germany

13.6.4.1.  Germany At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.6.4.1.1. Allergy

13.6.4.1.2. Anemia

13.6.4.1.3. Cholesterol

13.6.4.1.4. Drug abuse

13.6.4.1.5. Colorectal Screening

13.6.4.1.6. Glucose

13.6.4.1.7. Hepatitis C

13.6.4.1.8. HIV

13.6.4.1.9. Ovulation predictor

13.6.4.1.10. Pregnancy

13.6.4.1.11. Urinary tract infections

13.6.4.1.12. Yeast infections

13.6.4.1.13. COVID-19

13.6.4.1.14. Others

13.6.4.2.  Germany At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.6.4.2.1. Urine

13.6.4.2.2. Blood

13.6.4.2.3. Saliva

13.6.4.2.4. Stool

13.6.4.3.  Germany At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.4.3.1. Kids

13.6.4.3.2. Adults

13.6.4.4.  Germany At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.4.4.1. Retail Pharmacies

13.6.4.4.2. Hospital Pharmacies

13.6.4.4.3. Online Pharmacies

13.6.5. Italy

13.6.5.1.  Italy At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.6.5.1.1. Allergy

13.6.5.1.2. Anemia

13.6.5.1.3. Cholesterol

13.6.5.1.4. Drug abuse

13.6.5.1.5. Colorectal Screening

13.6.5.1.6. Glucose

13.6.5.1.7. Hepatitis C

13.6.5.1.8. HIV

13.6.5.1.9. Ovulation predictor

13.6.5.1.10. Pregnancy

13.6.5.1.11. Urinary tract infections

13.6.5.1.12. Yeast infections

13.6.5.1.13. COVID-19

13.6.5.1.14. Others

13.6.5.2.  Italy At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.6.5.2.1. Urine

13.6.5.2.2. Blood

13.6.5.2.3. Saliva

13.6.5.2.4. Stool

13.6.5.3.  Italy At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.5.3.1. Kids

13.6.5.3.2. Adults

13.6.5.4.  Italy At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.5.4.1. Retail Pharmacies

13.6.5.4.2. Hospital Pharmacies

13.6.5.4.3. Online Pharmacies

13.6.6. Nordic Countries

13.6.6.1.  Nordic Countries At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.6.6.1.1. Allergy

13.6.6.1.2. Anemia

13.6.6.1.3. Cholesterol

13.6.6.1.4. Drug abuse

13.6.6.1.5. Colorectal Screening

13.6.6.1.6. Glucose

13.6.6.1.7. Hepatitis C

13.6.6.1.8. HIV

13.6.6.1.9. Ovulation predictor

13.6.6.1.10. Pregnancy

13.6.6.1.11. Urinary tract infections

13.6.6.1.12. Yeast infections

13.6.6.1.13. COVID-19

13.6.6.1.14. Others

13.6.6.2.  Nordic Countries At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.6.6.2.1. Urine

13.6.6.2.2. Blood

13.6.6.2.3. Saliva

13.6.6.2.4. Stool

13.6.6.3.  Nordic Countries At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.6.3.1. Kids

13.6.6.3.2. Adults

13.6.6.4.  Nordic Countries At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.6.4.1. Retail Pharmacies

13.6.6.4.2. Hospital Pharmacies

13.6.6.4.3. Online Pharmacies

13.6.6.5.  Nordic Countries At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Country

13.6.6.5.1. Denmark

13.6.6.5.2. Finland

13.6.6.5.3. Iceland

13.6.6.5.4. Sweden

13.6.6.5.5. Norway

13.6.7. Benelux Union

13.6.7.1.  Benelux Union At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.6.7.1.1. Allergy

13.6.7.1.2. Anemia

13.6.7.1.3. Cholesterol

13.6.7.1.4. Drug abuse

13.6.7.1.5. Colorectal Screening

13.6.7.1.6. Glucose

13.6.7.1.7. Hepatitis C

13.6.7.1.8. HIV

13.6.7.1.9. Ovulation predictor

13.6.7.1.10. Pregnancy

13.6.7.1.11. Urinary tract infections

13.6.7.1.12. Yeast infections

13.6.7.1.13. COVID-19

13.6.7.1.14. Others

13.6.7.2.  Benelux Union At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.6.7.2.1. Urine

13.6.7.2.2. Blood

13.6.7.2.3. Saliva

13.6.7.2.4. Stool

13.6.7.3.  Benelux Union At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.7.3.1. Kids

13.6.7.3.2. Adults

13.6.7.4.  Benelux Union At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.7.4.1. Retail Pharmacies

13.6.7.4.2. Hospital Pharmacies

13.6.7.4.3. Online Pharmacies

13.6.7.5.  Benelux Union At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Country

13.6.7.5.1. Belgium

13.6.7.5.2. The Netherlands

13.6.7.5.3. Luxembourg

13.6.8. Rest of Europe

13.6.8.1.  Rest of Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

13.6.8.1.1. Allergy

13.6.8.1.2. Anemia

13.6.8.1.3. Cholesterol

13.6.8.1.4. Drug abuse

13.6.8.1.5. Colorectal Screening

13.6.8.1.6. Glucose

13.6.8.1.7. Hepatitis C

13.6.8.1.8. HIV

13.6.8.1.9. Ovulation predictor

13.6.8.1.10. Pregnancy

13.6.8.1.11. Urinary tract infections

13.6.8.1.12. Yeast infections

13.6.8.1.13. COVID-19

13.6.8.1.14. Others

13.6.8.2.  Rest of Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

13.6.8.2.1. Urine

13.6.8.2.2. Blood

13.6.8.2.3. Saliva

13.6.8.2.4. Stool

13.6.8.3.  Rest of Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

13.6.8.3.1. Kids

13.6.8.3.2. Adults

13.6.8.4.  Rest of Europe At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

13.6.8.4.1. Retail Pharmacies

13.6.8.4.2. Hospital Pharmacies

13.6.8.4.3. Online Pharmacies

13.7. Key Segment for Channeling Investments

13.7.1. By Country

13.7.2. By Indications

13.7.3. By Sample Type

13.7.4. By Age Group

13.7.5. By Distribution Channel

14. Asia Pacific At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

14.1. Overview

14.1.1. Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn)

14.2. Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.2.1. Allergy

14.2.2. Anemia

14.2.3. Cholesterol

14.2.4. Drug abuse

14.2.5. Colorectal Screening

14.2.6. Glucose

14.2.7. Hepatitis C

14.2.8. HIV

14.2.9. Ovulation predictor

14.2.10. Pregnancy

14.2.11. Urinary tract infections

14.2.12. Yeast infections

14.2.13. COVID-19

14.2.14. Others

14.3. Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.3.1. Urine

14.3.2. Blood

14.3.3. Saliva

14.3.4. Stool

14.4. Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.4.1. Kids

14.4.2. Adults

14.5. Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.5.1. Retail Pharmacies

14.5.2. Hospital Pharmacies

14.5.3. Online Pharmacies

14.6. Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Country

14.6.1. China

14.6.1.1.  China At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.6.1.1.1. Allergy

14.6.1.1.2. Anemia

14.6.1.1.3. Cholesterol

14.6.1.1.4. Drug abuse

14.6.1.1.5. Colorectal Screening

14.6.1.1.6. Glucose

14.6.1.1.7. Hepatitis C

14.6.1.1.8. HIV

14.6.1.1.9. Ovulation predictor

14.6.1.1.10. Pregnancy

14.6.1.1.11. Urinary tract infections

14.6.1.1.12. Yeast infections

14.6.1.1.13. COVID-19

14.6.1.1.14. Others

14.6.1.2.  China At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.6.1.2.1. Urine

14.6.1.2.2. Blood

14.6.1.2.3. Saliva

14.6.1.2.4. Stool

14.6.1.3.  China At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.1.3.1. Kids

14.6.1.3.2. Adults

14.6.1.4.  China At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.1.4.1. Retail Pharmacies

14.6.1.4.2. Hospital Pharmacies

14.6.1.4.3. Online Pharmacies

14.6.2. Japan

14.6.2.1.  Japan At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.6.2.1.1. Allergy

14.6.2.1.2. Anemia

14.6.2.1.3. Cholesterol

14.6.2.1.4. Drug abuse

14.6.2.1.5. Colorectal Screening

14.6.2.1.6. Glucose

14.6.2.1.7. Hepatitis C

14.6.2.1.8. HIV

14.6.2.1.9. Ovulation predictor

14.6.2.1.10. Pregnancy

14.6.2.1.11. Urinary tract infections

14.6.2.1.12. Yeast infections

14.6.2.1.13. COVID-19

14.6.2.1.14. Others

14.6.2.2.  Japan At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.6.2.2.1. Urine

14.6.2.2.2. Blood

14.6.2.2.3. Saliva

14.6.2.2.4. Stool

14.6.2.3.  Japan At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.2.3.1. Kids

14.6.2.3.2. Adults

14.6.2.4.  Japan At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.2.4.1. Retail Pharmacies

14.6.2.4.2. Hospital Pharmacies

14.6.2.4.3. Online Pharmacies

14.6.3. India

14.6.3.1.  India At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.6.3.1.1. Allergy

14.6.3.1.2. Anemia

14.6.3.1.3. Cholesterol

14.6.3.1.4. Drug abuse

14.6.3.1.5. Colorectal Screening

14.6.3.1.6. Glucose

14.6.3.1.7. Hepatitis C

14.6.3.1.8. HIV

14.6.3.1.9. Ovulation predictor

14.6.3.1.10. Pregnancy

14.6.3.1.11. Urinary tract infections

14.6.3.1.12. Yeast infections

14.6.3.1.13. COVID-19

14.6.3.1.14. Others

14.6.3.2.  India At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.6.3.2.1. Urine

14.6.3.2.2. Blood

14.6.3.2.3. Saliva

14.6.3.2.4. Stool

14.6.3.3.  India At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.3.3.1. Kids

14.6.3.3.2. Adults

14.6.3.4.  India At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.3.4.1. Retail Pharmacies

14.6.3.4.2. Hospital Pharmacies

14.6.3.4.3. Online Pharmacies

14.6.4. New Zealand

14.6.4.1.  New Zealand At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.6.4.1.1. Allergy

14.6.4.1.2. Anemia

14.6.4.1.3. Cholesterol

14.6.4.1.4. Drug abuse

14.6.4.1.5. Colorectal Screening

14.6.4.1.6. Glucose

14.6.4.1.7. Hepatitis C

14.6.4.1.8. HIV

14.6.4.1.9. Ovulation predictor

14.6.4.1.10. Pregnancy

14.6.4.1.11. Urinary tract infections

14.6.4.1.12. Yeast infections

14.6.4.1.13. COVID-19

14.6.4.1.14. Others

14.6.4.2.  New Zealand At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.6.4.2.1. Urine

14.6.4.2.2. Blood

14.6.4.2.3. Saliva

14.6.4.2.4. Stool

14.6.4.3.  New Zealand At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.4.3.1. Kids

14.6.4.3.2. Adults

14.6.4.4.  New Zealand At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.4.4.1. Retail Pharmacies

14.6.4.4.2. Hospital Pharmacies

14.6.4.4.3. Online Pharmacies

14.6.5. Australia

14.6.5.1.  Australia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.6.5.1.1. Allergy

14.6.5.1.2. Anemia

14.6.5.1.3. Cholesterol

14.6.5.1.4. Drug abuse

14.6.5.1.5. Colorectal Screening

14.6.5.1.6. Glucose

14.6.5.1.7. Hepatitis C

14.6.5.1.8. HIV

14.6.5.1.9. Ovulation predictor

14.6.5.1.10. Pregnancy

14.6.5.1.11. Urinary tract infections

14.6.5.1.12. Yeast infections

14.6.5.1.13. COVID-19

14.6.5.1.14. Others

14.6.5.2.  Australia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.6.5.2.1. Urine

14.6.5.2.2. Blood

14.6.5.2.3. Saliva

14.6.5.2.4. Stool

14.6.5.3.  Australia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.5.3.1. Kids

14.6.5.3.2. Adults

14.6.5.4.  Australia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.5.4.1. Retail Pharmacies

14.6.5.4.2. Hospital Pharmacies

14.6.5.4.3. Online Pharmacies

14.6.6. South Korea

14.6.6.1.  South Korea At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.6.6.1.1. Allergy

14.6.6.1.2. Anemia

14.6.6.1.3. Cholesterol

14.6.6.1.4. Drug abuse

14.6.6.1.5. Colorectal Screening

14.6.6.1.6. Glucose

14.6.6.1.7. Hepatitis C

14.6.6.1.8. HIV

14.6.6.1.9. Ovulation predictor

14.6.6.1.10. Pregnancy

14.6.6.1.11. Urinary tract infections

14.6.6.1.12. Yeast infections

14.6.6.1.13. COVID-19

14.6.6.1.14. Others

14.6.6.2.  South Korea At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.6.6.2.1. Urine

14.6.6.2.2. Blood

14.6.6.2.3. Saliva

14.6.6.2.4. Stool

14.6.6.3.  South Korea At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.6.3.1. Kids

14.6.6.3.2. Adults

14.6.6.4.  South Korea At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.6.4.1. Retail Pharmacies

14.6.6.4.2. Hospital Pharmacies

14.6.6.4.3. Online Pharmacies

14.6.7. Southeast Asia

14.6.7.1.  Southeast Asia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.6.7.1.1. Allergy

14.6.7.1.2. Anemia

14.6.7.1.3. Cholesterol

14.6.7.1.4. Drug abuse

14.6.7.1.5. Colorectal Screening

14.6.7.1.6. Glucose

14.6.7.1.7. Hepatitis C

14.6.7.1.8. HIV

14.6.7.1.9. Ovulation predictor

14.6.7.1.10. Pregnancy

14.6.7.1.11. Urinary tract infections

14.6.7.1.12. Yeast infections

14.6.7.1.13. COVID-19

14.6.7.1.14. Others

14.6.7.2.  Southeast Asia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.6.7.2.1. Urine

14.6.7.2.2. Blood

14.6.7.2.3. Saliva

14.6.7.2.4. Stool

14.6.7.3.  Southeast Asia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.7.3.1. Kids

14.6.7.3.2. Adults

14.6.7.4.  Southeast Asia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.7.4.1. Retail Pharmacies

14.6.7.4.2. Hospital Pharmacies

14.6.7.4.3. Online Pharmacies

14.6.7.5.  Southeast Asia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Country

14.6.7.5.1. Indonesia

14.6.7.5.2. Thailand

14.6.7.5.3. Malaysia

14.6.7.5.4. Singapore

14.6.7.5.5. Rest of Southeast Asia

14.6.8. Rest of Asia Pacific

14.6.8.1.  Rest of Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

14.6.8.1.1. Allergy

14.6.8.1.2. Anemia

14.6.8.1.3. Cholesterol

14.6.8.1.4. Drug abuse

14.6.8.1.5. Colorectal Screening

14.6.8.1.6. Glucose

14.6.8.1.7. Hepatitis C

14.6.8.1.8. HIV

14.6.8.1.9. Ovulation predictor

14.6.8.1.10. Pregnancy

14.6.8.1.11. Urinary tract infections

14.6.8.1.12. Yeast infections

14.6.8.1.13. COVID-19

14.6.8.1.14. Others

14.6.8.2.  Rest of Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

14.6.8.2.1. Urine

14.6.8.2.2. Blood

14.6.8.2.3. Saliva

14.6.8.2.4. Stool

14.6.8.3.  Rest of Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

14.6.8.3.1. Kids

14.6.8.3.2. Adults

14.6.8.4.  Rest of Asia Pacific At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

14.6.8.4.1. Retail Pharmacies

14.6.8.4.2. Hospital Pharmacies

14.6.8.4.3. Online Pharmacies

14.7. Key Segment for Channeling Investments

14.7.1. By Country

14.7.2. By Indications

14.7.3. By Sample Type

14.7.4. By Age Group

14.7.5. By Distribution Channel

15. Middle East and Africa At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

15.1. Overview

15.1.1. Middle East and Africa At-Home Diagnostic Testing Market Revenue (US$ Mn)

15.2. Middle East and Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

15.2.1. Allergy

15.2.2. Anemia

15.2.3. Cholesterol

15.2.4. Drug abuse

15.2.5. Colorectal Screening

15.2.6. Glucose

15.2.7. Hepatitis C

15.2.8. HIV

15.2.9. Ovulation predictor

15.2.10. Pregnancy

15.2.11. Urinary tract infections

15.2.12. Yeast infections

15.2.13. COVID-19

15.2.14. Others

15.3. Middle East and Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.3.1. Urine

15.3.2. Blood

15.3.3. Saliva

15.3.4. Stool

15.4. Middle East and Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

15.4.1. Kids

15.4.2. Adults

15.5. Middle East and Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.5.1. Retail Pharmacies

15.5.2. Hospital Pharmacies

15.5.3. Online Pharmacies

15.6. Middle East and Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Country

15.6.1. Saudi Arabia

15.6.1.1.  Saudi Arabia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

15.6.1.1.1. Allergy

15.6.1.1.2. Anemia

15.6.1.1.3. Cholesterol

15.6.1.1.4. Drug abuse

15.6.1.1.5. Colorectal Screening

15.6.1.1.6. Glucose

15.6.1.1.7. Hepatitis C

15.6.1.1.8. HIV

15.6.1.1.9. Ovulation predictor

15.6.1.1.10. Pregnancy

15.6.1.1.11. Urinary tract infections

15.6.1.1.12. Yeast infections

15.6.1.1.13. COVID-19

15.6.1.1.14. Others

15.6.1.2.  Saudi Arabia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.6.1.2.1. Urine

15.6.1.2.2. Blood

15.6.1.2.3. Saliva

15.6.1.2.4. Stool

15.6.1.3.  Saudi Arabia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

15.6.1.3.1. Kids

15.6.1.3.2. Adults

15.6.1.4.  Saudi Arabia At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.1.4.1. Retail Pharmacies

15.6.1.4.2. Hospital Pharmacies

15.6.1.4.3. Online Pharmacies

15.6.2. UAE

15.6.2.1.  UAE At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

15.6.2.1.1. Allergy

15.6.2.1.2. Anemia

15.6.2.1.3. Cholesterol

15.6.2.1.4. Drug abuse

15.6.2.1.5. Colorectal Screening

15.6.2.1.6. Glucose

15.6.2.1.7. Hepatitis C

15.6.2.1.8. HIV

15.6.2.1.9. Ovulation predictor

15.6.2.1.10. Pregnancy

15.6.2.1.11. Urinary tract infections

15.6.2.1.12. Yeast infections

15.6.2.1.13. COVID-19

15.6.2.1.14. Others

15.6.2.2.  UAE At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.6.2.2.1. Urine

15.6.2.2.2. Blood

15.6.2.2.3. Saliva

15.6.2.2.4. Stool

15.6.2.3.  UAE At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

15.6.2.3.1. Kids

15.6.2.3.2. Adults

15.6.2.4.  UAE At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.2.4.1. Retail Pharmacies

15.6.2.4.2. Hospital Pharmacies

15.6.2.4.3. Online Pharmacies

15.6.3. Egypt

15.6.3.1.  Egypt At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

15.6.3.1.1. Allergy

15.6.3.1.2. Anemia

15.6.3.1.3. Cholesterol

15.6.3.1.4. Drug abuse

15.6.3.1.5. Colorectal Screening

15.6.3.1.6. Glucose

15.6.3.1.7. Hepatitis C

15.6.3.1.8. HIV

15.6.3.1.9. Ovulation predictor

15.6.3.1.10. Pregnancy

15.6.3.1.11. Urinary tract infections

15.6.3.1.12. Yeast infections

15.6.3.1.13. COVID-19

15.6.3.1.14. Others

15.6.3.2.  Egypt At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.6.3.2.1. Urine

15.6.3.2.2. Blood

15.6.3.2.3. Saliva

15.6.3.2.4. Stool

15.6.3.3.  Egypt At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

15.6.3.3.1. Kids

15.6.3.3.2. Adults

15.6.3.4.  Egypt At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.3.4.1. Retail Pharmacies

15.6.3.4.2. Hospital Pharmacies

15.6.3.4.3. Online Pharmacies

15.6.4. Kuwait

15.6.4.1.  Kuwait At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

15.6.4.1.1. Allergy

15.6.4.1.2. Anemia

15.6.4.1.3. Cholesterol

15.6.4.1.4. Drug abuse

15.6.4.1.5. Colorectal Screening

15.6.4.1.6. Glucose

15.6.4.1.7. Hepatitis C

15.6.4.1.8. HIV

15.6.4.1.9. Ovulation predictor

15.6.4.1.10. Pregnancy

15.6.4.1.11. Urinary tract infections

15.6.4.1.12. Yeast infections

15.6.4.1.13. COVID-19

15.6.4.1.14. Others

15.6.4.2.  Kuwait At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.6.4.2.1. Urine

15.6.4.2.2. Blood

15.6.4.2.3. Saliva

15.6.4.2.4. Stool

15.6.4.3.  Kuwait At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

15.6.4.3.1. Kids

15.6.4.3.2. Adults

15.6.4.4.  Kuwait At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.4.4.1. Retail Pharmacies

15.6.4.4.2. Hospital Pharmacies

15.6.4.4.3. Online Pharmacies

15.6.5. South Africa

15.6.5.1.  South Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

15.6.5.1.1. Allergy

15.6.5.1.2. Anemia

15.6.5.1.3. Cholesterol

15.6.5.1.4. Drug abuse

15.6.5.1.5. Colorectal Screening

15.6.5.1.6. Glucose

15.6.5.1.7. Hepatitis C

15.6.5.1.8. HIV

15.6.5.1.9. Ovulation predictor

15.6.5.1.10. Pregnancy

15.6.5.1.11. Urinary tract infections

15.6.5.1.12. Yeast infections

15.6.5.1.13. COVID-19

15.6.5.1.14. Others

15.6.5.2.  South Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.6.5.2.1. Urine

15.6.5.2.2. Blood

15.6.5.2.3. Saliva

15.6.5.2.4. Stool

15.6.5.3.  South Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

15.6.5.3.1. Kids

15.6.5.3.2. Adults

15.6.5.4.  South Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.5.4.1. Retail Pharmacies

15.6.5.4.2. Hospital Pharmacies

15.6.5.4.3. Online Pharmacies

15.6.6. Rest of Middle East & Africa

15.6.6.1.  Rest of Middle East & Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

15.6.6.1.1. Allergy

15.6.6.1.2. Anemia

15.6.6.1.3. Cholesterol

15.6.6.1.4. Drug abuse

15.6.6.1.5. Colorectal Screening

15.6.6.1.6. Glucose

15.6.6.1.7. Hepatitis C

15.6.6.1.8. HIV

15.6.6.1.9. Ovulation predictor

15.6.6.1.10. Pregnancy

15.6.6.1.11. Urinary tract infections

15.6.6.1.12. Yeast infections

15.6.6.1.13. COVID-19

15.6.6.1.14. Others

15.6.6.2.  Rest of Middle East & Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

15.6.6.2.1. Urine

15.6.6.2.2. Blood

15.6.6.2.3. Saliva

15.6.6.2.4. Stool

15.6.6.3.  Rest of Middle East & Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

15.6.6.3.1. Kids

15.6.6.3.2. Adults

15.6.6.4.  Rest of Middle East & Africa At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

15.6.6.4.1. Retail Pharmacies

15.6.6.4.2. Hospital Pharmacies

15.6.6.4.3. Online Pharmacies

15.7. Key Segment for Channeling Investments

15.7.1. By Country

15.7.2. By Indications

15.7.3. By Sample Type

15.7.4. By Age Group

15.7.5. By Distribution Channel

16. Latin America At-Home Diagnostic Testing Market Analysis and Forecasts, 2023 - 2031

16.1. Overview

16.1.1. Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn)

16.2. Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

16.2.1. Allergy

16.2.2. Anemia

16.2.3. Cholesterol

16.2.4. Drug abuse

16.2.5. Colorectal Screening

16.2.6. Glucose

16.2.7. Hepatitis C

16.2.8. HIV

16.2.9. Ovulation predictor

16.2.10. Pregnancy

16.2.11. Urinary tract infections

16.2.12. Yeast infections

16.2.13. COVID-19

16.2.14. Others

16.3. Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.3.1. Urine

16.3.2. Blood

16.3.3. Saliva

16.3.4. Stool

16.4. Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

16.4.1. Kids

16.4.2. Adults

16.5. Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.5.1. Retail Pharmacies

16.5.2. Hospital Pharmacies

16.5.3. Online Pharmacies

16.6. Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Country

16.6.1. Brazil

16.6.1.1.  Brazil At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

16.6.1.1.1. Allergy

16.6.1.1.2. Anemia

16.6.1.1.3. Cholesterol

16.6.1.1.4. Drug abuse

16.6.1.1.5. Colorectal Screening

16.6.1.1.6. Glucose

16.6.1.1.7. Hepatitis C

16.6.1.1.8. HIV

16.6.1.1.9. Ovulation predictor

16.6.1.1.10. Pregnancy

16.6.1.1.11. Urinary tract infections

16.6.1.1.12. Yeast infections

16.6.1.1.13. COVID-19

16.6.1.1.14. Others

16.6.1.2.  Brazil At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.6.1.2.1. Urine

16.6.1.2.2. Blood

16.6.1.2.3. Saliva

16.6.1.2.4. Stool

16.6.1.3.  Brazil At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

16.6.1.3.1. Kids

16.6.1.3.2. Adults

16.6.1.4.  Brazil At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.6.1.4.1. Retail Pharmacies

16.6.1.4.2. Hospital Pharmacies

16.6.1.4.3. Online Pharmacies

16.6.2. Argentina

16.6.2.1.  Argentina At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

16.6.2.1.1. Allergy

16.6.2.1.2. Anemia

16.6.2.1.3. Cholesterol

16.6.2.1.4. Drug abuse

16.6.2.1.5. Colorectal Screening

16.6.2.1.6. Glucose

16.6.2.1.7. Hepatitis C

16.6.2.1.8. HIV

16.6.2.1.9. Ovulation predictor

16.6.2.1.10. Pregnancy

16.6.2.1.11. Urinary tract infections

16.6.2.1.12. Yeast infections

16.6.2.1.13. COVID-19

16.6.2.1.14. Others

16.6.2.2.  Argentina At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.6.2.2.1. Urine

16.6.2.2.2. Blood

16.6.2.2.3. Saliva

16.6.2.2.4. Stool

16.6.2.3.  Argentina At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

16.6.2.3.1. Kids

16.6.2.3.2. Adults

16.6.2.4.  Argentina At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.6.2.4.1. Retail Pharmacies

16.6.2.4.2. Hospital Pharmacies

16.6.2.4.3. Online Pharmacies

16.6.3. Rest of Latin America

16.6.3.1.  Rest of Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Indications

16.6.3.1.1. Allergy

16.6.3.1.2. Anemia

16.6.3.1.3. Cholesterol

16.6.3.1.4. Drug abuse

16.6.3.1.5. Colorectal Screening

16.6.3.1.6. Glucose

16.6.3.1.7. Hepatitis C

16.6.3.1.8. HIV

16.6.3.1.9. Ovulation predictor

16.6.3.1.10. Pregnancy

16.6.3.1.11. Urinary tract infections

16.6.3.1.12. Yeast infections

16.6.3.1.13. COVID-19

16.6.3.1.14. Others

16.6.3.2.  Rest of Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Sample Type

16.6.3.2.1. Urine

16.6.3.2.2. Blood

16.6.3.2.3. Saliva

16.6.3.2.4. Stool

16.6.3.3.  Rest of Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Age Group

16.6.3.3.1. Kids

16.6.3.3.2. Adults

16.6.3.4.  Rest of Latin America At-Home Diagnostic Testing Market Revenue (US$ Mn) and Forecasts, By Distribution Channel

16.6.3.4.1. Retail Pharmacies

16.6.3.4.2. Hospital Pharmacies

16.6.3.4.3. Online Pharmacies

16.7. Key Segment for Channeling Investments

16.7.1. By Country

16.7.2. By Indications

16.7.3. By Sample Type

16.7.4. By Age Group

16.7.5. By Distribution Channel

17. Competitive Benchmarking

17.1. Brand Benchmarking

17.2. Market Share Analysis, 2022

17.3. Global Presence and Growth Strategies

17.3.1. Mergers and Acquisitions

17.3.2. Product Launches

17.3.3. Investments Trends

17.3.4. R&D Initiatives

18. Player Profiles

18.1. 23andMe

18.1.1. Company Details

18.1.2. Company Overview

18.1.3. Product Offerings

18.1.4. Key Developments

18.1.5. Financial Analysis

18.1.6. SWOT Analysis

18.1.7. Business Strategies

18.2. Abbott Laboratories

18.2.1. Company Details

18.2.2. Company Overview

18.2.3. Product Offerings

18.2.4. Key Developments

18.2.5. Financial Analysis

18.2.6. SWOT Analysis

18.2.7. Business Strategies

18.3. ACON Laboratories, Inc.

18.3.1. Company Details

18.3.2. Company Overview

18.3.3. Product Offerings

18.3.4. Key Developments

18.3.5. Financial Analysis

18.3.6. SWOT Analysis

18.3.7. Business Strategies

18.4. ARKRAY Inc.

18.4.1. Company Details

18.4.2. Company Overview

18.4.3. Product Offerings

18.4.4. Key Developments

18.4.5. Financial Analysis

18.4.6. SWOT Analysis

18.4.7. Business Strategies

18.5. B. Braun Medical Ltd

18.5.1. Company Details

18.5.2. Company Overview

18.5.3. Product Offerings

18.5.4. Key Developments

18.5.5. Financial Analysis

18.5.6. SWOT Analysis

18.5.7. Business Strategies

18.6. BD (Becton, Dickinson and Company)

18.6.1. Company Details

18.6.2. Company Overview

18.6.3. Product Offerings

18.6.4. Key Developments

18.6.5. Financial Analysis

18.6.6. SWOT Analysis

18.6.7. Business Strategies

18.7. Bionime Corporation

18.7.1. Company Details

18.7.2. Company Overview

18.7.3. Product Offerings

18.7.4. Key Developments

18.7.5. Financial Analysis

18.7.6. SWOT Analysis

18.7.7. Business Strategies

18.8. Everlywell

18.8.1. Company Details

18.8.2. Company Overview

18.8.3. Product Offerings

18.8.4. Key Developments

18.8.5. Financial Analysis

18.8.6. SWOT Analysis

18.8.7. Business Strategies

18.9. F. Hoffmann-La Roche Ltd

18.9.1. Company Details

18.9.2. Company Overview

18.9.3. Product Offerings

18.9.4. Key Developments

18.9.5. Financial Analysis

18.9.6. SWOT Analysis

18.9.7. Business Strategies

18.10. Quidel Corporation

18.10.1. Company Details

18.10.2. Company Overview

18.10.3. Product Offerings

18.10.4. Key Developments

18.10.5. Financial Analysis

18.10.6. SWOT Analysis

18.10.7. Business Strategies

18.11. Roche Diagnostics

18.11.1. Company Details

18.11.2. Company Overview

18.11.3. Product Offerings

18.11.4. Key Developments

18.11.5. Financial Analysis

18.11.6. SWOT Analysis

18.11.7. Business Strategies

18.12. Siemens Healthineers

18.12.1. Company Details

18.12.2. Company Overview

18.12.3. Product Offerings

18.12.4. Key Developments

18.12.5. Financial Analysis

18.12.6. SWOT Analysis

18.12.7. Business Strategies

18.13. Thermo Fisher Scientific

18.13.1. Company Details

18.13.2. Company Overview

18.13.3. Product Offerings

18.13.4. Key Developments

18.13.5. Financial Analysis

18.13.6. SWOT Analysis

18.13.7. Business Strategies

18.14. Other Market Participants

19. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User.

 

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com